Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q19104080> ?p ?o }
Showing triples 1 to 22 of
22
with 100 triples per page.
- Q19104080 subject Q6987473.
- Q19104080 subject Q7499018.
- Q19104080 subject Q8430418.
- Q19104080 subject Q8586782.
- Q19104080 abstract "Executive Order 13139— entitled Improving Health Protection of Military Personnel Participating in Particular Military Operations — as an executive order (EO) issued by U.S. President Bill Clinton on 30 September 1999. It outlines the conditions under which Investigational New Drug (IND) and off-label pharmaceuticals can be administered to U.S. service members. An “off-label" indication is a use of a drug in a manner (or for a condition) other than that for which they were originally licensed. EO13139 provides the US Secretary of Defense guidance regarding the provision of IND products or products unapproved for their intended use as antidotes to chemical, biological, or radiological weapons; stipulates that the U.S. government will administer products approved by the U.S. Food and Drug Administration only for their intended use; provides the circumstances and controls under which IND products may be used.It also stipulates that to administer an IND product, informed consent must be obtained from individual service members. However, the President of the United States may waive informed consent (at the request of the Secretary of Defense and only the Secretary of Defense) if:Informed consent is not feasibleInformed consent is contrary to the best interests of the service memberObtaining informed consent is not in the best interests of national security.".
- Q19104080 wikiPageExternalLink 99-26078.pdf.
- Q19104080 wikiPageWikiLink Q1124.
- Q19104080 wikiPageWikiLink Q11696.
- Q19104080 wikiPageWikiLink Q119697.
- Q19104080 wikiPageWikiLink Q1338798.
- Q19104080 wikiPageWikiLink Q204711.
- Q19104080 wikiPageWikiLink Q2518691.
- Q19104080 wikiPageWikiLink Q265653.
- Q19104080 wikiPageWikiLink Q5440362.
- Q19104080 wikiPageWikiLink Q6060674.
- Q19104080 wikiPageWikiLink Q6987473.
- Q19104080 wikiPageWikiLink Q7499018.
- Q19104080 wikiPageWikiLink Q764527.
- Q19104080 wikiPageWikiLink Q8430418.
- Q19104080 wikiPageWikiLink Q8586782.
- Q19104080 comment "Executive Order 13139— entitled Improving Health Protection of Military Personnel Participating in Particular Military Operations — as an executive order (EO) issued by U.S. President Bill Clinton on 30 September 1999. It outlines the conditions under which Investigational New Drug (IND) and off-label pharmaceuticals can be administered to U.S. service members. An “off-label" indication is a use of a drug in a manner (or for a condition) other than that for which they were originally licensed.".
- Q19104080 label "Executive Order 13139".